Sodium Glucose Cotransporter Inhibition in Acute Heart Failure: An In-Depth Review

Inhibitors of the sodium glucose cotransporters were initially developed for the treatment of type 2 diabetes but have since been shown to provide many benefits in heart failure, especially in heart failure with reduced ejection fraction (HFrEF). Already an established and foundational therapy for H...

Full description

Saved in:
Bibliographic Details
Main Authors: Joey A. Mercier, MD, FRCPC, Aditya Sharma, MD, FRCPC, Magdaline Zawadka, MD, Thang Nguyen, MD, FRCPC
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X2400653X
Tags: Add Tag
No Tags, Be the first to tag this record!